info@hytanpeptides.com
Hytan Peptides — Peptide CDMORequest Project Quote
Technical guide

Cosmetic Peptide Identity: How INCI, CAS and Sequence Fit Together

Cosmetic peptide raw material vials, molecular model and specification sheet on a laboratory bench; conceptual image

A cosmetic peptide can appear under an INCI name, a CAS number, a trade name and a sequence description. Those fields answer different questions. Before comparing two quotations, establish that both suppliers mean the same material, including its modifications, counterion and supplied form.

What each identifier actually tells you

  • INCI name: a cosmetic ingredient name used in product labelling. It helps the formulation and regulatory teams identify the ingredient in a finished cosmetic.
  • CAS number: a registry identifier for a substance. A number can help narrow a search, but it does not describe every grade, counterion, mixture or presentation offered under a commercial product name.
  • Sequence and modifications: the technical identity needed to compare peptide offers. Ask the supplier to specify relevant terminal groups, substitutions or other modifications in the confidential project brief.
  • Salt, carrier and supplied form: the practical material delivered to the formulator. A powder, solution or blend can require a different specification even when a marketing name is the same.

The European Commission’s CosIng database allows searches by CAS and lists common ingredient names. The Commission expressly says that an INCI entry in CosIng does not approve an ingredient for cosmetic use. The applicable rules are in Regulation (EC) No 1223/2009 and its annexes.

A useful identity comparison for a peptide RFQ

Confirm the target before discussing price

Send one controlled description to every shortlisted supplier. It should name the intended application and destination market, the requested ingredient name, any available CAS number, the sequence or supplier reference, the desired supplied form, and the documents your team needs. If the sequence is confidential, agree on an NDA before sending it.

Compare the underlying evidence

Ask for a current specification and a representative, clearly marked sample COA. Compare the material description, test names, acceptance criteria, units and stated form. A representative COA shows a documentation format; it is not evidence for a future production batch. The final batch should be tied to its own identity and release records.

  1. Resolve any difference in INCI name, CAS reference or sequence description.
  2. Record the salt form, carrier or blend composition if these affect formulation use.
  3. Agree which analytical attributes and documents belong in the purchase specification.
  4. Have the finished-product team review safety and labelling for its destination market.

Regulatory boundary for cosmetic buyers

In the EU, the Commission’s glossary informs common ingredient naming for labels; it is not a positive list of authorised cosmetic ingredients. The EU responsible person must arrange a safety assessment for the finished cosmetic and maintain its product information file under Regulation (EC) No 1223/2009. Article 11 requires that file to be kept for 10 years after the last batch is placed on the market. In the US, the FDA explains that most cosmetic ingredients are not preapproved, while companies marketing cosmetics remain responsible for safety under labelled or customary use. Neither a catalogue listing nor an INCI name settles those obligations.

For a project-specific review, browse our peptide materials, see the cosmetic peptide CDMO scope, or submit the identity and market details through the project brief.

FAQ

Does an INCI name prove that a peptide is approved for cosmetics?

No. CosIng provides ingredient information and naming, but the European Commission says an INCI entry does not itself authorise cosmetic use. Finished-product safety and market requirements still need review.

Can two suppliers quote the same CAS number but different supplied materials?

Yes. The quotation can differ in salt form, carrier, concentration, grade or packaging. Compare the complete material description and proposed specification.

What should remain confidential in the first enquiry?

A product name and intended market often suffice for an initial discussion. Share proprietary sequence or formulation details under the confidentiality arrangement appropriate to the project.

Primary references

← More guides